Receptor tyrosine kinase | Urothelial carcinoma tumors n (%) | Urothelial carcinoma cell lines n (%) |
---|---|---|
PDGFRa | 1 (11%) | 1 (25%) |
PDGFRb | 3 (33%) | 1 (25%) |
KIT | 3 (33%) | 1 (25%) |
Flt-3 | 2 (22%) | 0 (0%) |
M-CSF R | 3 (33%) | 1 (25%) |
VEGFR1 | 2 (22%) | 0 (0%) |
VEGFR2 | 3 (33%) | 0 (0%) |
VEGFR3 | 5 (56%) | 0 (0%) |
EGFR | 9 (100%) | 4 (100%) |
ErbB2 | 8 (89%) | 4 (100%) |
ErbB3 | 3 (33%) | 2 (50%) |
ErbB4 | 4 (44%) | 1 (25%) |
FGFR1 | 4 (44%) | 1 (25%) |
FGFR2 | 4 (44%) | 1 (25%) |
FGFR3 | 4 (44%) | 1 (25%) |
FGFR4 | 2 (22%) | 0 (0%) |
Insulin R | 7 (78%) | 2 (50%) |
c-RET | 3 (33%) | 1 (25%) |
ROR1 | 8 (89%) | 4 (100%) |
ROR2 | 8 (89%) | 3 (75%) |
Tie-1 | 9 (100%) | 4 (100%) |
Tie-2 | 7 (78%) | 3 (75%) |